HER2 Expression of CTC to Predict Response in HER2-low Advanced Breast Cancer Patients Treated With ADC

Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer

NCT07132502 ·Status: NOT_YET_RECRUITING

Dynamic Monitoring of HER2 and ctDNA Specific Mutations in Patients With Recurrent or Metastatic Breast Cancer by Digital PCR

NCT03947736 ·Status: UNKNOWN

Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy

NCT05923268 ·Status: COMPLETED ·Phase: NA

The Detection of Circulating Tumor Cells (CTCs) in Patients With Breast Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

NCT02450357 ·Status: COMPLETED

Study of Circulating and Tumor Biomarkers in Breast Cancer Patients

NCT01866202 ·Status: UNKNOWN

microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin

NCT02656589 ·Status: UNKNOWN

99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization

NCT03546478 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2.

NCT05203497 ·Status: COMPLETED ·Phase: PHASE1

Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions

NCT05510037 ·Status: COMPLETED

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

NCT00493350 ·Status: COMPLETED

MRD in High-risk EBC

NCT06566729 ·Status: ACTIVE_NOT_RECRUITING

Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast Cancer

NCT05775822 ·Status: COMPLETED ·Phase: NA

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

NCT06479460 ·Status: RECRUITING

A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

NCT03047889 ·Status: UNKNOWN

Circulating Tumor Cells Screen for Breast Cancer

NCT05633680 ·Status: UNKNOWN

99mTc-ABH2 SPECT/CT in Breast Cancer

NCT06194565 ·Status: RECRUITING ·Phase: NA

Discordant HER2/Neu Status of Breast Cancer.

NCT01935739 ·Status: COMPLETED

A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

NCT06833853 ·Status: RECRUITING

Biological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast Cancer

NCT05734950 ·Status: UNKNOWN

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NCT03723928 ·Status: RECRUITING ·Phase: NA

Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant Chemotherapy

NCT03381092 ·Status: UNKNOWN

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

NCT05754047 ·Status: COMPLETED

Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

NCT03688035 ·Status: UNKNOWN

HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02

NCT04040686 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

NCT00898014 ·Status: COMPLETED